In addition to helping make treatment decisions, COTA's real-world data platform can help oncologists understand and identify areas where there is treatment variability and help them work to contain cost in the long run, explained C.K. Wang, MD, senior medical director, COTA.
In addition to helping make treatment decisions, COTA's real-world data platform can help oncologists understand and identify areas where there is treatment variability and help them work to contain cost in the long run, explained C.K. Wang, MD, senior medical director, COTA.
Transcript
How does COTA’s real-world data platform help oncologists make decisions about their patients?
Oncologists today in coming up with a treatment plan, first of all, it’s a very complex process, but they resort to multiple sources. First and foremost is drug approvals. Secondly, the well-established treatment guidelines, and third, clinicians often draw from their own personal experience. That said, the patients that are sitting in from of them may not fit into any of those previous constructs. For example, today, only 3% to 5% of cancer patients participate in clinical trials, which ultimately lead to drug approvals. It is likely that patient sitting in front of the provider in that patient population was never represented or was not well-represented in that clinical trial.
So, what real-world data does and what COTA’s platform can do is to surface real-world treatment approaches for those patients, as well as real-world toxicities and outcomes. All of these different factors can help a clinician then ultimately make the best treatment decision for the patient. Now that said, real-world data and COTA’s platform is currently not being used at the point of care, but there are many exploratory discussions looking into this. I think that ultimately, how this can benefit providers, in addition to making treatment decisions, is to allow them insight into how they’ve treated these patients in the past, and therefore understand and identify areas where there is tremendous treatment variability and help them work to contain cost in the long run.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More